Sign in Subscribe
COVID-19

Global Anti-Osteoporosis Therapy & Fracture Healing Market to Reach $19.12 Billion by 2027

Strategic Insights

— 2 min read

The Global Anti-Osteoporosis Therapy & Fracture Healing Market is expected to experience significant growth, driven by the rising geriatric population, rapid urbanization, and changing lifestyles that contribute to bone diseases. The market size was estimated at USD 10.89 billion in 2020 and is projected to reach USD 19.12 billion by 2027, growing at a CAGR of 8.36%. The market is influenced by factors such as the growing incidence of post-menopausal osteoporosis in women, the introduction of new drugs, and ongoing awareness of osteoporosis' impact on health.

Key Takeaways:

  • The market is driven by the rising geriatric population worldwide, with the number of people aged 65 and older expected to reach 1.5 billion by 2050.
  • The rapid urbanization and changing lifestyles are increasing the occurrence of bone diseases, with 39% of the global population expected to be urban dwellers by 2050.
  • The market share of the leading vendors in the Global Anti-Osteoporosis Therapy & Fracture Healing Market is expected to increase, with companies like Amgen Inc., GlaxoSmithKline plc, and Johnson & Johnson dominating the market.
  • The Competitive Strategic Window analysis suggests that vendors should adopt merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
  • The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anti-Osteoporosis Therapy & Fracture Healing Market based on Business Strategy and Product Satisfaction.
  • The Market Share Analysis offers insights into how vendors are performing in terms of revenue generation and customer base compared to others, with companies like Pfizer, Inc. and Merck and Company Inc. holding 15% and 10% market share respectively.
  • The report addresses questions such as market size and forecast, inhibiting factors and impact of COVID-19, and product development & innovation.

Statistics:

  • The Global Anti-Osteoporosis Therapy & Fracture Healing Market size is expected to reach USD 19.12 billion by 2027, growing at a CAGR of 8.36%.
  • The market is driven by the rising geriatric population, with the number of people aged 65 and older expected to reach 1.5 billion by 2050.
  • The rapid urbanization and changing lifestyles are increasing the occurrence of bone diseases, with 39% of the global population expected to be urban dwellers by 2050.
  • The market share of the leading vendors in the Global Anti-Osteoporosis Therapy & Fracture Healing Market is expected to increase, with companies like Amgen Inc., GlaxoSmithKline plc, and Johnson & Johnson dominating the market.
  • The Competitive Strategic Window analysis suggests that vendors should adopt merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Sources:

  • "Anti-Osteoporosis Therapy & Fracture Healing Market Research Report by Drug, by Route Of Administration, by Distribution, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report, ResearchAndMarkets.com
  • "M2 Communications" press release, M2 Communications
  • "ResearchAndMarkets.com" press release, ResearchAndMarkets.com

Read more